医学
脂肪肝
疾病
流行病学
医疗保健
肝病学
疾病管理
家庭医学
人口
肝病
重症监护医学
环境卫生
内科学
经济增长
经济
帕金森病
作者
Mohammed Eslam,Shiv Kumar Sarin,Vincent W. S. Wong,Jian Gao Fan,Takumi Kawaguchi,Sang Hoon Ahn,Ming‐Hua Zheng,Gamal Shiha,Yusuf Yılmaz,Rino Alvani Gani,Shahinul Alam,Yock Young Dan,Jia–Horng Kao,Hamid Salehiniya,Ian Homer,Wah Kheong Chan,Diana A. Payawal,Soek Siam Tan,Tawesak Tanwandee,Leon A. Adams,Manoj Kumar,Masao Omata,Jacob George
标识
DOI:10.1007/s12072-020-10094-2
摘要
Metabolic associated fatty liver disease (MAFLD) is the principal worldwide cause of liver disease and affects nearly a quarter of the global population. The objective of this work was to present the clinical practice guidelines of the Asian Pacific Association for the Study of the Liver (APASL) on MAFLD. The guidelines cover various aspects of MAFLD including its epidemiology, diagnosis, screening, assessment, and treatment. The document is intended for practical use and for setting the stage for advancing clinical practice, knowledge, and research of MAFLD in adults, with specific reference to special groups as necessary. The guidelines also seek to improve patient care and awareness of the disease and assist stakeholders in the decision-making process by providing evidence-based data. The guidelines take into consideration the burden of clinical management for the healthcare sector.
科研通智能强力驱动
Strongly Powered by AbleSci AI